中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:( Chuanlin DING)

1.17β-Estradiol and fulvestrant inhibit glomerular mesangial cell fibrogenesis downstream of protein kinase C activation

Yichen LI ; Chuanlin SHI ; Xuansheng DING

Journal of China Pharmaceutical University 2017;48(2):208-213

2.Generation and functional analysis of EBV LMP2A specific CTL elicited by DC transfected with recombinant adenovirus in vitro

Kun YAO ; Guangyong PENG ; Chuanlin DING ; Feng ZHOU ; Fangyi XIE ;

Chinese Journal of Immunology 1999;0(12):-

3.Functional effects of dendritic cells transfected with Epstein-Barr virus latent membrane protein 2A recombinant adenovirus.

Guanyong PENG ; Kun YAU ; Fangyi XIE ; Jijun XU ; Chuanlin DING

Chinese Journal of Experimental and Clinical Virology 2002;16(2):171-175

4.Practice of the reform of performance appraisal and the income allocation system of public hospitals in Shanghai

Yongjin GUO ; Ming ZHAO ; Jue CEN ; Yan XU ; Jiechun GAO ; Chuanlin LI ; Wenjing XU ; Meijian DING ; Jinfu WANG ; Lingping HUANG ; Rong TAO ; Jianping CHEN

Chinese Journal of Hospital Administration 2015;(8):570-573

5. Specifications for diagnosis and treatment of non-neonatal tetanus

Chuanlin WANG ; Si LIU ; Qingjun CHEN ; Zhujun SHAO ; Jifeng WU ; Zhao FAN ; Peige WANG ; Zhenggang ZHU ; Pin LAN ; Jianguo LI ; Yishan ZHENG ; Wubing HE ; Zhe XU ; Weidong TANG ; Jinman PANG ; Zhihong BAN ; Shuqing YANG ; Wentao DING ; Xifu ZHENG ; Qilong ZHANG

Chinese Journal of Trauma 2020;36(1):18-23

6. Specifications for diagnosis and treatment of non-neonatal tetanus

Chuanlin WANG ; Si LIU ; Qingjun CHEN ; Zhujun SHAO ; Jifeng WU ; Zhao FAN ; Peige WANG ; Zhenggang ZHU ; Pin LAN ; Jianguo LI ; Yishan ZHENG ; Wubing HE ; Zhe XU ; Weidong TANG ; Jinman PANG ; Zhihong BAN ; Shuqing YANG ; Wentao DING ; Xifu ZHENG ; Qilong ZHANG

Chinese Journal of Preventive Medicine 2019;53(12):1206-1211

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO